As of 2026-09-17, the Relative Valuation of Bristol-Myers Squibb Co (BMY) is 118.92 USD. This relative valuation is based on P/E multiples. With the latest stock price at 63.60 USD, the upside of Bristol-Myers Squibb Co based on Relative Valuation is 87.0%.
The range of the Relative Valuation is 78.32 - 171.38 USD.
| Range | Selected | |
| Trailing P/E multiples | 24.5x - 37.7x | 33.0x |
| Forward P/E multiples | 19.0x - 29.7x | 21.2x |
| Fair Price | 78.32 - 171.38 | 118.92 |
| Upside | 23.1% - 169.5% | 87.0% |
| Date | P/E |
| 2026-09-16 | 13.99 |
| 2026-09-15 | 14.02 |
| 2026-09-14 | 14.10 |
| 2026-09-11 | 14.00 |
| 2026-09-10 | 14.02 |
| 2026-09-09 | 14.17 |
| 2026-09-08 | 14.23 |
| 2026-09-04 | 14.70 |
| 2026-09-03 | 14.98 |
| 2026-09-02 | 14.88 |
| 2026-09-01 | 14.72 |
| 2026-08-31 | 14.70 |
| 2026-08-28 | 14.65 |
| 2026-08-27 | 14.73 |
| 2026-08-26 | 14.86 |
| 2026-08-25 | 14.94 |
| 2026-08-24 | 14.80 |
| 2026-08-21 | 14.74 |
| 2026-08-20 | 14.40 |
| 2026-08-19 | 14.87 |
| 2026-08-18 | 14.53 |
| 2026-08-17 | 14.22 |
| 2026-08-14 | 14.04 |
| 2026-08-13 | 14.22 |
| 2026-08-12 | 14.01 |
| 2026-08-11 | 13.99 |
| 2026-08-10 | 14.26 |
| 2026-08-07 | 14.24 |
| 2026-08-06 | 14.11 |
| 2026-08-05 | 14.00 |
| 2026-08-04 | 14.49 |
| 2026-08-03 | 14.40 |
| 2026-07-31 | 14.37 |
| 2026-07-30 | 14.27 |
| 2026-07-29 | 13.88 |
| 2026-07-28 | 13.99 |
| 2026-07-27 | 13.76 |
| 2026-07-24 | 13.66 |
| 2026-07-23 | 13.53 |
| 2026-07-22 | 13.37 |
| 2026-07-21 | 13.40 |
| 2026-07-20 | 13.23 |
| 2026-07-17 | 13.36 |
| 2026-07-16 | 13.31 |
| 2026-07-15 | 12.92 |
| 2026-07-14 | 12.53 |
| 2026-07-13 | 13.05 |
| 2026-07-10 | 12.67 |
| 2026-07-09 | 12.75 |
| 2026-07-08 | 12.66 |